SCHEMBL3845762

SCHEMBL3845762

N#Cc1ccc(-c2nn(C(c3ccccc3)(c3ccccc3)c3ccccc3)cc2B(O)O)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 1/20 0.36
SLC22A12 Q96S37 1/20 0.36
KIF11 P52732 1/20 0.35
EGLN2 Q96KS0 2/20 0.34
ALDH1A3 P47895 1/20 0.34
ACSS2 Q9NR19 1/20 0.34
ENPP2 Q13822 1/20 0.34
BAZ2B Q9UIF8 1/20 0.34
BAZ2A Q9UIF9 1/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
ATM Q13315 1/20 0.33
SMO Q99835 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
MAPK13 O15264 1/20 0.33
RAF1 P04049 1/20 0.33
MAPK12 P53778 1/20 0.33
MAPK11 Q15759 1/20 0.33
MAPK14 Q16539 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3848166 0.87 ADORA2A (0.41) PRKDCALDH1A3ENPP2SMOTSHR
SCHEMBL519708 0.87 KDM4E (0.33) MEN1KMT2AATM
SCHEMBL3846801 0.84 KMT2A (0.40) MEN1KMT2AATMNPC1RAB9A
SCHEMBL3846711 0.83 KDM4E (0.37) MEN1KMT2ANPC1RAB9A
SCHEMBL3847281 0.83 POLB (0.39) MEN1KMT2AMAPK13MAPK12MAPK11
SCHEMBL3847801 0.82 KIF11 (0.40) KIF11MEN1KMT2ASMONPC1
SCHEMBL3848108 0.81 MEN1 (0.46) MEN1KMT2AATMNPC1RAB9A
SCHEMBL3848952 0.81 PTGS2 (0.38) KIF11ALDH1A3MEN1KMT2ANPC1
SCHEMBL3854383 0.81 NOX1 (0.36) MEN1KMT2ASMONPC1RAB9A
SCHEMBL3852265 0.81 KIF11 (0.37) PRKDCSLC22A12KIF11ALDH1A3BAZ2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed